作为最常见的侏儒症类型，软骨发育不全（ACH）过去很长时间无特效疗法，直到2021年，“孤儿药之王”BioMarin研发的Vosoritide，作为首个获批药物，才开启了药物对症治疗时代。凭借独家优势，其2025年销售额高达9.27亿美元。
"But you need an oil price that makes that worthwhile. Unless you can generate sufficient money to justify that, it's very difficult to see the industry coming back."
。关于这个话题，safew官方版本下载提供了深入分析
[DATABASE_URL]="secure-env-demo/database-url"
Continue reading...